AVANT IMMUNOTHERAPEUTICS INC, S-3, EX-23.1, 2000-12-26

AVANT IMMUNOTHERAPEUTICS INC
S-3, EX-23.1, 2000-12-26
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Previous: AVANT IMMUNOTHERAPEUTICS INC, S-3, EX-5.1, 2000-12-26

Next: AVANT IMMUNOTHERAPEUTICS INC, S-3, EX-99.2, 2000-12-26



<PAGE>

                                  EXHIBIT 23.1

                       CONSENT OF INDEPENDENT ACCOUNTANTS

         We hereby consent to the incorporation by reference in this
Registration Statement on Form S-3 of our report dated February 14, 2000
relating to the financial statements, which appears in AVANT Immunotherapeutics,
Inc.'s Annual Report on Form 10-K/A for the year ended December 31, 1999. We
also consent to the reference to us under the heading "Experts" in such
Registration Statement.


/S/ PRICEWATERHOUSECOOPERS LLP
------------------------------
PricewaterhouseCoopers LLP



PricewaterhouseCoopers LLP
Boston, Massachusetts
December 22 2000